DOCS - Doximity Network Market Cap to Sales Volume

Symbol and logo of brand Doximity Corp (DOCS)

The battle for pharmaceutical giants' advertising budgets and pressure from new IT ecosystems are creating volatility, as evidenced by the price/sales ratio dynamics. Doximity, Inc. (DOCS) relies on cloud optimization of medical workflows and the high margins of a narrow niche of digital services in the US. The current value of 6.40 captures this metric, helping to determine the balance between market expectations and the actual revenue of Doximity, Inc. (DOCS).

DOCS doximity.com Market Cap to Revenue (07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Doximity Corp (DOCS)

- price and consensus price forecast:
General company analysis:DOCS (doximity.com)
Core merchandise of doximity.com

To objectively measure the operational success of Doximity, Inc. (DOCS), investors must compare market capitalization with actual sales volume. By analyzing the current P/S multiple, one can assess the extent to which the market premiums the highly profitable healthcare professional ecosystem and high business margins, thereby determining the long-term sustainability of the share price relative to the company's expansion rates within the pharmaceutical marketing segment.

Who Doximity, Inc. competes with

Price-to-Revenue Coefficient veeva.com|HealthEquity - Market Cap to Revenue|Market Cap to Sales Volume WAY (Waystar Health)|CRVL: Market Cap to Revenue|Price to Sales Privia Medical Group|HURN (Huron Consulting Group) - Market Cap to Revenue|certara.com - Market Capitalization-to-Revenue Ratio|OMCL (Omnicell) - P/S Multiple|GoodRx Inc (GDRX) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Schrödinger Inc. (SDGR)|Phreesia Health - Market Cap to Revenue Ratio|P/S Multiple OMDA (Omada Health Inc)|EVH - Market Cap to Revenue|HSTM: Market Cap to Revenue|Price-to-Revenue Coefficient Definitive Healthcare Corp DH|CCSI: P/S Multiple|Market Cap to Revenue Ratio AGL|Price-to-Revenue Ratio Absci|Price to Sales soyoung.com SY|P/S Multiple NRC|Market Cap to Revenue Spok Holdings Inc SPOK|Price-to-Revenue Ratio OptimizeRx Corp. OPRX|Price-to-Revenue Coefficient TruBridge Corp (TBRG)|Simulations Plus, Inc. - P/S Multiple|Price-to-Revenue Coefficient SOPHiA GENETICS SA SOPH|HCAT (Health Catalyst) - Market Cap to Revenue|CCLD: Market Cap to Sales Volume|Market Cap to Revenue RSSS|DLHC: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio OneMedNet Corporation (ONMD)|Market Cap to Revenue scienture.com SCNX|P/S Multiple HCTI (Healthcare Triangle, Inc.)|iSpecimen Inc (ISPC) - Price to Sales|Bullfrog AI Holdings Inc - P/S Multiple|WORX (SCWorx Inc) - Market Cap to Revenue Ratio|MSPR: P/S Multiple|Market Cap to Revenue Ratio ICCT|Price-to-Revenue Ratio TRxADE HEALTH|Price to Sales Orgenesis Inc ORGS|Market Cap to Revenue RCM (R1 RCM Inc.)|Sharecare Inc - Market Cap to Revenue Ratio|P/S Multiple STRM (Streamline Health Solutions)|Price-to-Revenue Coefficient syrahealth.com (SYRA)|AMEH - Price-to-Revenue Ratio|Model N Inc (MODN) - Market Cap to Revenue|NXGN: P/S Multiple